MECP2 and neoplasm: Inhibition of HOXD3 counterbalanced the tumor‐stimulating effect of␣MeCP2 in migration, invasion, and angiogenesis of HCCs, indicating that increasing MeCP2 expression promotes metastasis, invasion, and angiogenesis of HCCs.